Bert Malengier-Devlies

Postdoc

Background

2022-present: Postdoc at the University of Edinburgh (GB)

2016-2022: Doctoral thesis at the University of Leuven (BE)

Research summary

Bert Malengier‐Devlies completed his PhD thesis at the REGA Institute (KU Leuven, Belgium) on innate immune cells in autoinflammatory manifestations including systemic juvenile idiopathic arthritis and macrophage activation syndrome in September 2021. Guided by Prof. Patrick Matthys, Prof. Paul Proost, and Prof. Carine Wouters, his research focuses on neutrophil homeostasis and extramedullary myelopoiesis as well as on the biology of IL‐17, IL‐22 and IL‐1β. His work is truly translational from mouse models to clinical sample analysis. During the pandemic, in a collaborative effort between KU Leuven, UZ Leuven, and VIB, Bert Malengier‐Devlies performed extensive research on changes in the immunological landscape during the COVID‐19 disease and evaluated the immunological response towards a newly developed COVID‐19 vaccine candidate. In February 2022, Bert Malengier-Devlies joined the lab of Rebecca Gentek working on the ontogeny of synovial macrophages. 

Current research interests

- Early life adversity - Immune programming - Innate immune system